Paul Perco

Title: Paul Perco: Innovator in Acute Kidney Injury Risk Testing

Introduction

Paul Perco is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of acute kidney injury risk. With a total of 2 patents to his name, Perco's work is paving the way for advancements in healthcare.

Latest Patents

Perco's latest patents focus on innovative methods for determining the risk of acute kidney injury. The first patent involves a method that determines the amount of one or more markers selected from REN, SLC38A4, IL17RB, TMEM149, FLRT3, and CATSPERG in a sample. This invention aims to provide a reliable assessment of kidney health. The second patent relates to identifying markers of acute kidney failure, utilizing a method that measures the amount of a marker selected from VCAN, NRP1, CCL2, CCL19, COL3A1, and GZMM in a sample. Both patents highlight Perco's commitment to improving patient outcomes through innovative diagnostic techniques.

Career Highlights

Throughout his career, Paul Perco has worked with various organizations, contributing his expertise to the field of medical research. His work has been instrumental in developing methods that enhance the understanding of kidney health and disease.

Collaborations

Perco has collaborated with notable professionals in his field, including Rainer Oberbauer and Alexander Kainz. These collaborations have further enriched his research and innovation efforts.

Conclusion

Paul Perco's contributions to the field of acute kidney injury risk testing exemplify the impact of innovation in healthcare. His patents and collaborations reflect a dedication to advancing medical diagnostics and improving patient care.